IngredientsThe common name "Weak Jumby Pepper" is applied, in different contexts, to two botanically distinct plants. The primary plant associated with this name in the dietary supplement and ethnopharmacological literature is Piper amalago L., a member of the family Piperaceae. The second, a smaller herbaceous species, is Microtea debilis Sw., classified in the family Microteaceae and formally recognized under this common name in taxonomic databases. These two plants are unrelated and should not be conflated; the majority of pharmacological and phytochemical research concerns Piper amalago, while Microtea debilis carries the English vernacular name in official governmental and taxonomic records.
The U.S. Fish & Wildlife Service lists Microtea debilis under the common name "weak jumby pepper," placing it in the Kingdom Plantae, Genus Microtea. According to the Global Biodiversity Information Facility (GBIF) Backbone Taxonomy, Microtea debilis was described by Olof Swartz and published in 1788, and belongs to the kingdom Plantae, phylum Tracheophyta, class Magnoliopsida, order Caryophyllales, family Microteaceae, genus Microtea. The genus Microtea, known collectively as the "jumby peppers," comprises flowering plants in the family Microteaceae native to the Caribbean islands, Central America, and tropical South America, with ten species currently accepted. Microtea debilis Sw. is specifically identified as the weak jumby pepper, and the genus Microtea was originally placed in the family Phytolaccaceae but is now placed in its own family, Microteaceae.
In the dietary supplement and ethnobotanical literature, however, the ingredient sold and studied as Weak Jumby Pepper is overwhelmingly described as Piper amalago. Piper amalago has traditionally been used in Caribbean folk medicine to address digestive complaints, including indigestion. Piper amalago, a member of the Piperaceae family, is commonly described as "pariparoba, jaborandi-manso, and pimenta-da-jamaica" in Brazil, and is a native perennial tree that can grow up to a height of 7 m, known for its aromatic properties, producing and storing volatile oil within its glandular trichomes and secretory cells.
Piper amalago is distributed across a wide range spanning from Argentina, Brazil, Bolivia, and Peru northward to the Caribbean and through Central America to Mexico, inhabiting moist or wet thickets or mixed forest at elevations up to 2,600 metres in Guatemala. Microtea debilis, meanwhile, has a documented taxon range that includes Amazonia and various Brazilian states including Acre, Bahia, Amapá, and Pará, as recorded in the Brazilian Flora 2020 project.
Microtea debilis is known in English as "Weak Jumby Pepper" and in French as "Demoiselle." Piper amalago carries multiple vernacular names in Brazil, including "pariparoba," "jaborandi-manso," and "pimenta-da-jamaica." Synonyms documented for Microtea debilis in GBIF include Microtea debilis var. ovata Delile, Microtea debilis var. rhombifolia Moq., Microtea ovata Delile ex Moq., and Schollera debilis (Sw.) Rohr.
Ethnobotanical records and historical herbal texts from the Caribbean and parts of Central and South America mention the use of Weak Jumby Pepper leaves and berries as a remedy for stomach ailments, colic, and mild digestive disturbances, with the plant often prepared as a tea or infusion consumed after meals or during episodes of digestive discomfort. Infusions or teas prepared from the plant were administered for their calming effects on the stomach, and poultices made from the leaves were applied to minor wounds or inflamed areas. In the scientific literature, extracts used in preclinical studies have included ethanolic extracts (EEPA), methanolic extracts, aqueous extracts (AE), hydroalcoholic extracts (HE), and volatile oil (VO) distilled from plant material.
Weak Jumby Pepper is a traditional botanical ingredient that has been utilized in various cultures, particularly in Caribbean folk medicine, for its purported health benefits, historically used as a spice and as a remedy for digestive complaints and to support general well-being. Traditionally, local healers valued it for its warming, aromatic properties, using both its leaves and berries in a range of remedies, with historical records and oral traditions highlighting its use in soothing digestive discomfort, relieving colds, and easing mild pain or headaches.
In traditional Brazilian medicine, leaves of P. amalago are used as a diuretic for the treatment of urinary calculi illness and heart issues, employed as a healing agent for burns, abscesses, boils, wounds, and insect bites, and consumed to alleviate inflammation, chest pain, gastrointestinal problems, headaches, nosebleeds, and anxiety.
In ethnobotanical records from the Caribbean and parts of Central and South America, Weak Jumby Pepper is cited as a remedy for stomach discomfort, flatulence, and related gastrointestinal issues, with traditional healers employing its leaves and fruits in teas or decoctions to help soothe digestive upset and promote relief from bloating.
In an ethnobotanical survey of the Q'eqchi' Maya of Belize, high use of plants was found for neurological disorders including headaches, susto (a culture-bound illness associated with fright), and epilepsy. The Q'eqchi' Maya healers of southern Belize were found to generally recognize and treat epilepsy/seizures, headache, madness, fright (susto), depression, numbness, insomnia, and stress with herbal remedies. Piperaceae species, including Piper amalago, were among the selected botanical families used for neurological and mental health conditions.
In Brazilian folk medicine, P. amalago is commonly used as a diuretic and for the treatment of urinary calculus disease. In the state of Mato Grosso do Sul, Brazil, Piper species are used for several disorders, and an ethnobotanical survey in Dourados, MS, Brazil, found that 10.8% of identified plant families were from Piper species, demonstrating the large number of species from this genus in the region.
Weak Jumby Pepper, known botanically as Piper amalago, is cited in Caribbean traditional medicine for various uses including the treatment of burns and scalds, a use primarily rooted in folk practices rather than scientific validation. Ethnobotanical surveys and folk medicine records indicate that the leaves and sometimes the berries of this plant are prepared as teas or decoctions to address stomach discomfort, cramps, and other digestive issues. Healers also frequently blended it with other botanicals such as ginger, lemongrass, or soursop leaves to enhance its effects or create balanced tonics.
Phytochemical investigations have shown that plants of the family Piperaceae have several compounds such as esters, phenolic ethers, volatile oils, lignans, and pyrrolidine alkaloids. Phytochemical analyses of the genus Piper specifically have demonstrated the occurrence of alkaloids, amides, propenylphenols, lignans, neolignans, steroids, pyrones, chalcones, dihydrochalcones, flavones, and terpenoids.
In addition to studies regarding its pharmacological potential, phytochemical analyses of P. amalago have identified several bioactive compounds, including amides, chalcones, flavonoids, alkaloids, phenolic compounds, and essential oils, especially monoterpenic and sesquiterpene hydrocarbons.
Phytochemical analysis of P. amalago leaves has shown the presence of amides, alkaloids, condensed tannins, flavonoids, and triterpenes.
Gas chromatography–mass spectrometry analyses of the volatile oil of P. amalago identified 47 compounds, with β-cyclogermacrene, spathulenol, β-phellandrene, and α-pinene standing out; among the compounds also found in aqueous and hydroalcoholic extracts by liquid chromatography–mass spectrometry, glycosylated flavones, organic acids, amino acids, and amides were highlighted.
Specific amide compounds include methoxy-methylenedioxy cis-cinnamoyl pyrrolidine, methoxy-methylenedioxy trans-cinnamoyl pyrrolidine, and cyclobutene-2,4-bis-(1,3-benzodioxol-5-methoxy-6-yl)-1,3-dicarboxapyrrolidide.
Analyses of the essential oil of P. amalago leaves have also shown the prevalence of sesquiterpene hydrocarbons such as bicyclogermacrene, β-phellandrene, and germacrene D, with substantial amounts of monoterpene hydrocarbons such as α-pinene, and sesquiterpenoids such as spathulenol.
Amides represent the major chemical compounds that have been characterized in P. amalago. The Piper genus is known for its special phytochemistry, and its phytochemical investigation over the past four decades has led to the isolation of over 300 different amide alkaloids (often referred to as "piperamides") with a wide range of biological activities.
Phytochemical screening has also detected triterpenes and/or sterols in Piper amalago, among other species, through Liebermann-Bouchard testing.
Phytochemical investigation has identified piperamides in P. amalago, though investigation of their effect on the GABA system was not made until more recently. Bioassay-guided fractionation identified a furofuran lignan, a molecule with structural similarity to yangambin, with high affinity for the GABAA-BZD receptor as the principal bioactive.
The amides obtained from P. amalago appeared to be active components because they proved to be anti-nociceptive and anti-hyperalgesic in models of acute pain.
In an in vitro GABAA competitive binding assay, a 66.5 µg/mL concentration of P. amalago ethanol extract displaced 50% of the GABAA–BZD receptor ligand [3H]-Flunitrazepam. Bioassay-guided fractionation identified a furofuran lignan with high affinity for the GABAA-BZD receptor as the principal bioactive, and the results suggest that the ethnobotanical use of this plant may have a pharmacological basis in its anxiolytic activity, as demonstrated in animal behaviour tests.
A published study aimed to investigate the safety and the renal and cardiovascular effects of the volatile oil and the aqueous and hydroalcoholic extracts from P. amalago. The study's title indicates that the cardiorenal effects of Piper amalago are mediated by the nitric oxide/cyclic guanosine monophosphate pathway and the voltage-dependent potassium channels.
The ethanolic extract of P. amalago (EEPA) was effective for inhibition of pain and arthritic parameters; the amides obtained seemed to be the active components present in the EEPA because they proved to be anti-nociceptive and anti-hyperalgesic in models of acute pain. Considering that few drugs are currently available for the treatment of chronic pain, especially neuropathic pain, these results may have clinical relevance and open new possibilities for the development of new anti-hyperalgesic and anti-arthritic agents from P. amalago.
The following sections summarize the available scientific evidence. Unless otherwise stated, all studies are preclinical (animal or in vitro). No human clinical trials have been published for Weak Jumby Pepper / Piper amalago as of the available literature. Evidence strength is rated accordingly.
Traditional Use: Weak Jumby Pepper (Piper amalago) has traditionally been used in Caribbean folk medicine to address digestive complaints including indigestion, with ethnobotanical records and historical herbal texts from the Caribbean and parts of Central and South America mentioning the use of its leaves and berries as a remedy for stomach ailments, colic, and mild digestive disturbances.
Scientific Evidence: Despite these longstanding traditional uses, there is a lack of robust clinical or pharmacological studies specifically validating the efficacy or safety of Weak Jumby Pepper for treating indigestion, with most references being anecdotal or based on historical usage rather than controlled scientific investigation. Some studies of related Piper species (such as Piper nigrum and Piper longum) suggest possible carminative or digestive stimulant effects, but these results cannot be directly extrapolated to Weak Jumby Pepper without further research.
Evidence Strength: Very weak — traditional and anecdotal only; no controlled studies directly on this species for gastrointestinal complaints.
Traditional Use: In an ethnobotanical survey of the Q'eqchi' Maya of Belize, high use of plants for neurological disorders including headaches and susto (a culture-bound illness associated with fright) was documented.
Scientific Evidence (Animal/In vitro): Extracts of P. amalago had significant anxiolytic activity in all behavioral tests, with the strongest activity in the Social Interaction (SI) and Conditioned Emotional Response (CER) paradigms. In an in vitro GABAA competitive binding assay, a 66.5 µg/mL concentration of the ethanol extract displaced 50% of the GABAA-BZD receptor ligand [3H]-Flunitrazepam, and bioassay-guided fractionation identified a furofuran lignan with structural similarity to yangambin as the principal bioactive with high affinity for the GABAA-BZD receptor.
A neurobehavioral study showed that the methanolic extract from leaves of P. amalago acts on the central nervous system, with anxiogenic properties in rats evaluated in the elevated plus-maze model, affecting locomotion and exploration in this model, but without inducing genetic toxicity.
Evidence Strength: Preliminary — supported by in vitro receptor binding data and animal behavioral studies only; no human clinical trials.
Traditional Use: P. amalago is commonly used in folk medicine as a diuretic and for the treatment of urinary calculus disease.
Scientific Evidence (Animal): According to results from a published study, P. amalago extracts showed diuretic and natriuretic activity and antilithiasic effects. The smallest dose (30 mg/kg) of the aqueous extract (AE) and hydroalcoholic extract (HE) caused a significant increase in urinary volume 8 and 24 hours after administration compared to the control.
Evidence Strength: Preliminary animal data; no human clinical trials confirming these effects.
Traditional Use: Piper amalago L. is traditionally used due to its anti-inflammatory, analgesic, diuretic, and antiparasitic properties.
Scientific Evidence (Animal): Scientific evidence has demonstrated that the extract of P. amalago has anti-inflammatory, diuretic, antilithiasic, antinociceptive, anti-hyperalgesic, and antiarthritic effects in preclinical models, in addition to antiparasitic activity against Schistosoma and Leishmania. Related Piper species such as Piper nigrum (black pepper) have demonstrated antispasmodic and anti-inflammatory effects in laboratory studies, which could theoretically support traditional use, though such findings cannot be directly extrapolated to Weak Jumby Pepper without further research.
Evidence Strength: Preliminary — animal and in vitro studies only; no human clinical evidence.
Scientific Evidence (In vitro/Animal): Pharmacological studies performed with P. amalago showed antimicrobial, schistosomicidal, anti-Leishmania, and healing activities in preclinical models. The essential oils, extracts, and isolated compounds of P. amalago were shown to possess antioxidant, insecticidal, antibacterial, anti-inflammatory, antileishmanial, cytotoxicity, acaricidal, anxiolytic, antilithiatic, antihyperalgesic, antinociceptive, antiarthritic, diuretic, wound healing, schistosomicidal, brine shrimp, cysteine protease, as well as neurobehavioral and toxicological activities.
Evidence Strength: Preliminary in vitro and animal studies only; no controlled human trials.
Traditional Use: Piper amalago L. is a medicinal plant traditionally used as a healing agent for wounds, burns, abscesses, boils, and insect bites.
Scientific Evidence: The topical application of the aqueous extract produced from P. amalago leaves aided in the healing of a lacerated wound in the left thumb of a patient with type 2 diabetes mellitus over a period of 15 days in a study by Santos et al. (2020). This report represents a single case study and cannot be taken as controlled clinical evidence.
No clinical trials or pharmacological studies have been published to confirm its effectiveness or safety for burn treatment, and while some related Piper species contain compounds with anti-inflammatory or antimicrobial properties, this does not constitute direct evidence for Weak Jumby Pepper in burn treatment.
Evidence Strength: Very weak — one anecdotal case report; no controlled clinical trials.
No standardized dosage has been established for human use. The following dosages appear only in preclinical (animal) research and are presented solely as reported in those sources.
No human clinical trials have been conducted. No standardized extract, dose, or dosage form for dietary supplement use has been established or validated.
A study evaluating the toxicological safety of EEPA through subacute toxicity and genotoxicity assays in rodents tested 100, 200, or 300 mg/kg in female Wistar rats by gavage for 28 days, and found that in subacute toxicity the extract induced an increase in the food and water intakes, as well as in the liver absolute weight, and in the heart and kidney relative weights.
EEPA also provoked alterations in histopathological analysis of liver and in hemato-biochemical parameters, evidenced by a decrease in hematocrit levels and albumin levels, and an increase in the number of platelets and in alkaline phosphatase and cholesterol levels.
A study by Stein et al. demonstrated signs of subacute toxicity in tests with Piper amalago, showing reduction in hematocrit, increase in platelet counts and serum levels of cholesterol and alkaline phosphatase; the authors suggested the possibility of toxicity with the extended use of this substance.
EEPA, at doses of 17.5, 175, and 1,750 mg/kg, did not present genotoxic nor mutagenic properties in the comet and micronucleus tests conducted. A study by Lopes et al. (2012) also demonstrated the safety of the methanolic extract in an acute toxicity test, in addition to the absence of genotoxic and mutagenic activity at doses of 250 and 420 mg/kg.
Nevertheless, these data do not exclude a possible genotoxicity at other doses, as well as in other types of extractions, nor do they guarantee the safety of this extract after administration for a prolonged period.
The literature demonstrates safety from the point of view of mutagenicity and genotoxicity for all extracts under study, but there may be subacute oral toxicity with the use of Piper amalago, and its use for extended periods must be carefully analyzed. Use for short periods of time, such as for the acute treatment of injuries, can still be considered after the conduction of these studies.
Few studies have focused on the adverse effects of Piper amalago, compromising its safe use. From a scientific perspective, research on Weak Jumby Pepper remains limited. Robust clinical trials in humans are scarce, and definitive evidence regarding its efficacy and safety in nutritional products is still emerging.
No herb-drug interaction studies specific to Weak Jumby Pepper or Piper amalago have been identified in the peer-reviewed literature. Given the observed effects on hepatic tissue weights and biochemical parameters (including liver enzymes, cholesterol, and albumin) in subacute animal studies, interactions with hepatotoxic drugs, anticoagulants, or diuretic medications cannot be excluded but have not been formally evaluated.
Preliminary phytochemical analyses suggest that Weak Jumby Pepper contains a diverse array of bioactive compounds, including alkaloids and phenolic substances, and some laboratory studies have indicated potential antioxidant and antimicrobial activities, supporting its historical application in promoting health and preserving foods. Considering that few drugs are currently available for the treatment of chronic pain, especially neuropathic pain, results from P. amalago research may have clinical relevance and open new possibilities for the development of new anti-hyperalgesic and anti-arthritic agents.
Despite its traditional reputation, there is very limited scientific research specifically addressing Piper amalago or "Weak Jumby Pepper" for the treatment of conditions such as abdominal pain. Most of the available literature documents its use through interviews with traditional healers and herbalists rather than clinical or pharmacological studies. In summary, the use of Weak Jumby Pepper for indigestion and related conditions is primarily supported by traditional knowledge and anecdotal evidence, with minimal scientific validation available to date.
Health conditions that Weak jumby pepper may help support.
Body systems that Weak jumby pepper may help support.
Go back